Anne Bay-Jensen

Anne Bay-Jensen serves as Chief Technology Officer at Nordic Bioscience A/S. Nordic Bioscience A/S operates in the research sector with approximately 240.0 employees. The company is headquartered in Copenhagen, Capital Region of Denmark. Nordic Bioscience A/S generates annual revenue of 10000000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 947 executive contacts are available in Capital Region of Denmark.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Zendesk MailChimp SPF Bootstrap Framework Apache DoubleClick reCAPTCHA Google Tag Manager Nginx Google Maps (Non Paid Users) DoubleClick Conversion YouTube Google Dynamic Remarketing Google Font API Google Analytics Mobile Friendly Google Maps

biomarkers predictive biomarkers translational biomarkers bioassay oncology fibrosis rheumatoid arthritis rheumatology cancer osteoporosis osteoarthritis assay development alzheimers clinical trials clinical development serological biomarkers consultancy scientific collaboration neurodegenerative conditions biotechnology hepatology dermatology cardiovascular diseases respiratory diseases gastroenterology prognostic biomarkers protein fingerprint precision medicine drug development clinical research tumor fibrosis ipf copd trial enrichment patient stratification biotechnology research biomarker technology nordic proteinfingerprint chronic diseases cancer biomarkers translational models immune-oncology caf biomarkers tumor stroma extracellular matrix fibrotic diseases diagnostic tests bioinformatics immuno-oncology regulatory compliance laboratory services fda guidelines metabolic dysregulation renal biomarkers neurology biomarkers gastroenterology biomarkers pulmonary fibrosis rheumatology biomarkers cardiovascular biomarkers quantitative analysis biomarker panels non-invasive biomarkers personalized treatments serum analysis pharmacodynamics protein fragments efficacy evaluation sample analysis commercial assays statistical support biomarker portfolio european union regulations biotech solutions therapeutic outcomes healthcare analytics regenerative medicine biobanking solutions healthcare collaboration biomarker analysis proteinfingerprint technology liver diseases gastrointestinal diseases neuroscience renal diseases cap-accredited laboratory drug candidate selection financial risk-sharing scientific excellence operational support research partnerships pharmaceutical industry biotech industry innovative treatments chronic disease research mode-of-action biomarkers disease-specific biomarkers patient care healthcare innovation strategic collaboration regulatory expertise data integrity scientific rigor hospital & health care health care health wellness & fitness consulting management consulting information technology & services

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Anne Bay-Jensen?

Anne Bay-Jensen's verified email address is available on MessageCEO. They currently work at Nordic Bioscience A/S. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Anne Bay-Jensen lead?

Anne Bay-Jensen is Chief Technology Officer at Nordic Bioscience A/S, a company in the research sector with 240.0 employees. The company is based in Copenhagen, Capital Region of Denmark.

What industry is Anne Bay-Jensen in?

Anne Bay-Jensen works in the research industry as Chief Technology Officer at Nordic Bioscience A/S. MessageCEO provides verified contact information for executives across all major industries.

Is Anne Bay-Jensen's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Anne Bay-Jensen's profile is kept up-to-date with the latest available information.

Last updated: April 22, 2026